156 related articles for article (PubMed ID: 31098751)
1. Pigmentation of conjunctival melanoma recurrences and outcome.
Brouwer NJ; Marinkovic M; Luyten GPM; Shields CL; Jager MJ
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1783-1788. PubMed ID: 31098751
[TBL] [Abstract][Full Text] [Related]
2. Lack of tumour pigmentation in conjunctival melanoma is associated with light iris colour and worse prognosis.
Brouwer NJ; Marinkovic M; Luyten GPM; Shields CL; Jager MJ
Br J Ophthalmol; 2019 Mar; 103(3):332-337. PubMed ID: 29777046
[TBL] [Abstract][Full Text] [Related]
3. [Melanoma of the conjunctiva and its treatment].
Zografos L; Uffer S; Gailloud C; Bercher L
Klin Monbl Augenheilkd; 1990 May; 196(5):285-9. PubMed ID: 2366455
[TBL] [Abstract][Full Text] [Related]
4. Pigmented lesions of the conjunctiva.
Farber M; Schutzer P; Mihm MC
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):971-8. PubMed ID: 9632007
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of a red chromagen in the diagnosis of melanocytic lesions of the conjunctiva.
Jiang K; Brownstein S; Lam K; Burns B; Farmer J
JAMA Ophthalmol; 2014 May; 132(5):622-9. PubMed ID: 24626521
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B
Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
[TBL] [Abstract][Full Text] [Related]
7. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].
Lommatzsch PK; Werschnik C
Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715
[TBL] [Abstract][Full Text] [Related]
8. A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.
Larsen AC; Dahmcke CM; Dahl C; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S
JAMA Ophthalmol; 2015 Nov; 133(11):1295-303. PubMed ID: 26425792
[TBL] [Abstract][Full Text] [Related]
9. Satellite in transit metastases in rapidly fatal conjunctival melanoma: implications for angiotropism and extravascular migratory metastasis (description of a murine model for conjunctival melanoma).
Barnhill RL; Lemaitre S; Lévy-Gabrielle C; Rodrigues M; Desjardins L; Dendale R; Vincent-Salomon A; Roman-Roman S; Lugassy C; Cassoux N
Pathology; 2016 Feb; 48(2):166-76. PubMed ID: 27020389
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
12. Treatment of conjunctival melanoma in a Dutch referral centre.
Brouwer NJ; Marinkovic M; van Duinen SG; Bleeker JC; Jager MJ; Luyten GPM
Br J Ophthalmol; 2018 Sep; 102(9):1277-1282. PubMed ID: 29122819
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmologic oncology: conjunctival malignant melanoma in association with sporadic dysplastic nevus syndrome.
Friedman RJ; Rodríguez-Sains R; Jakobiec F
J Dermatol Surg Oncol; 1987 Jan; 13(1):31-4. PubMed ID: 3794047
[No Abstract] [Full Text] [Related]
14. Advances in the management of conjunctival melanoma.
Vora GK; Demirci H; Marr B; Mruthyunjaya P
Surv Ophthalmol; 2017; 62(1):26-42. PubMed ID: 27321895
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival melanoma in the Netherlands: a nationwide study.
Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
[TBL] [Abstract][Full Text] [Related]
16. Benign conjunctival melanocytic lesions. Clinicopathologic features.
Folberg R; Jakobiec FA; Bernardino VB; Iwamoto T
Ophthalmology; 1989 Apr; 96(4):436-61. PubMed ID: 2657539
[TBL] [Abstract][Full Text] [Related]
17. [Treatment modalities for conjunctival melanoma].
Krause L; Mladenova A; Bechrakis NE; Kreusel KM; Plath T; Moser L; Foerster M
Klin Monbl Augenheilkd; 2009 Dec; 226(12):1012-6. PubMed ID: 20108195
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Algorithm for Conjunctival Melanocytic Lesions.
Dębicka-Kumela M; Romanowska-Dixon B; Karska-Basta I; Kowal J; Pociej-Marciak W; Markiewicz A
Anticancer Res; 2021 Jun; 41(6):3161-3167. PubMed ID: 34083311
[TBL] [Abstract][Full Text] [Related]
19. Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma.
Westekemper H; Karimi S; Süsskind D; Anastassiou G; Freistühler M; Steuhl KP; Bornfeld N; Schmid KW; Grabellus F
Br J Ophthalmol; 2011 Jun; 95(6):853-8. PubMed ID: 20956280
[TBL] [Abstract][Full Text] [Related]
20. Recurrent conjunctival melanoma with neuroidal spindle cell features.
Morris DA; Jakobiec FA; Henkind P; Della Rocca R; Iwamoto T
Ophthalmology; 1987 Jan; 94(1):56-60. PubMed ID: 3561958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
